Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07004751Not ApplicableRecruiting

Etiology of Febrile Illness in Nepal (DEFINe Study)

Role: lead

NCT06936007Completed

Hematological Manifestations in Systemic Lupus Erythematosus Patients

Role: lead

NCT06327867Not ApplicableNot Yet Recruiting

Comparison of Video Laryngoscopy Versus Direct Laryngoscopy for Orotracheal Intubation Among Adults in Emergency Department

Role: lead

NCT06304272Not ApplicableNot Yet Recruiting

Comparison Between Drinking Water and Normal Saline in Irrigating Traumatic Wound

Role: lead

NCT05292508Not ApplicableUnknown

Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test

Role: lead

NCT03630380Unknown

Accuracy of Clinical and Diagnostic Studies for Pneumonia in Children

Role: lead

NCT03312049Completed

Aflatoxin Birth Cohort Study Nepal (AflaCohort)

Role: collaborator

NCT02385513Phase 4Completed

PCV10 Immunogenicity Study Nepal 2015

Role: collaborator

NCT02949141Not ApplicableCompleted

Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in Nepal

Role: lead

All 9 trials loaded